The impact of telemonitoring upon hospice referral in the community: a randomized controlled trial

Figures & data

Table 1 Baseline characteristics of overall group and by randomized group for 205 patients

Characteristic	Total n = 205	Telemonitoring n = 102	Usual care n = 103	P-value
Age	80.3 ± 8.2	80.3 ± 8.9	80.2 ± 7.6	0.9427
Male, n (%)	94 (45.9)	50 (49.0)	44 (42.7)	0.3653
Grip strength	18.5 ± 9.0	18.2 ± 8.6	18.8 ± 9.4	0.6649
Timed Up and Go	14.6 ± 12.0	13.3 ± 6.8	15.8 ± 15.4	0.1521
Gait speed (m/sec)	0.70 ± 0.36	0.70 ± 0.38	0.70 ± 0.35	0.9238
ERA score	16.6 ± 6.2	16.7 ± 6.5	16.5 ± 6.0	0.8444
Kokmen mental status score	34.5 ± 2.3	34.5 ± 2.2	34.4 ± 2.4	0.8550
Barthel ADL	94.4 ± 9.2	94.3 ± 9.7	94.6 ± 8.7	0.8161
PHQ 9 score for depression	3.7 ± 3.8	4.0 ± 3.8	3.4 ± 3.7	0.2463
SF-12 physical	35.1 ± 11.0	35.5 ± 10.7	34.7 ± 11.3	0.5853
SF-12 mental	55.9 ± 8.0	54.8 ± 8.7	57.1 ± 7.1	0.0345

Notes: Continuous variables reported as mean ± standard deviation. Copyright © 2012, American Medical Association. All rights reserved. Adapted with permission from Takahashi PY, Pecina JL, Upatising B, et al. A randomized controlled trial of telemonitoring in older adults with multiple health issues to prevent hospitalizations and emergency department visits. Arch Intern Med. 2012;172(10):773–779.⁶

Abbreviations: ERA, Elder Risk Assessment; ADL, activities of daily living; PHQ, Physical Health Questionnaire.

Figure 1 Flow of patients from recruitment to randomization for 205 patients over 60 years.

Note: Copyright © 2012, American Medical Association. All rights reserved. Adapted with permission from Takahashi PY, Pecina JL, Upatising B, et al. A randomized controlled trial of telemonitoring in older adults with multiple health issues to prevent hospitalizations and emergency department visits. Arch Intern Med. 2012;172(10):773–779.⁶

Table 2 Hospice referrals in telemonitoring and usual care in 205 older adults

	Overall n = 194	Intervention n = 94	Usual care n = 100	P-value
Number (%) of patients in hospice during trial	13 (6.3)	9 (8.8)	4 (3.9)	0.1207
Mean number of hospice visits during trial (SD)	14.0 (21.8)	13.8 (24.4)	14.5 (17.4)	0.9588
Median (IQR)	2 (0–23)	2.0 (0.0–25.0)	11.5 (0.0–32.0)
Mean time (days) to hospice entry during trial (SD)	206.2 (112.8)	206.4 (89.9)	205.5 (171.2)	0.9923
Median (IQR)	204 (131–311)	204.0 (148.5–305.5)	224.5 (38.0–354.0)
Mean days in hospice during trial (SD)	76.8 (106.1)	57.9 (99.2)	119.3 (123.8)	0.3580
Median (IQR)	27 (8–61)	27.0 (5.5–57.5)	106.0 (11.0–240.75)

Abbreviation: IQR, interquartile range.

Figure 2 Time from enrollment to hospice entry among patients enrolled in hospice (n = 13).

Figure 3 Survival from enrollment in hospice care (n = 13).

TakahashiPYPecinaJLUpatisingBA randomized controlled trial of telemonitoring in older adults with multiple health issues to prevent hospitalizations and emergency department visitsArch Intern Med20121721077377922507696

 PubMedGoogle Scholar